Medicus PharmaMDCX

13F holders, Q4 2025 (December 31)
21holders +1
7new positions
6sold out
$1.53avg. 13F price*

At the end of Q4 2025, 21 institutions reported holding Medicus Pharma Ltd. (MDCX) in their 13F filings, up 1 from Q3 2025. 7 opened new positions and 6 sold out. The largest holders were Armistice Capital, LLC ($2.8M), Interchange Capital Partners, LLC ($2.4M) and Private Advisor Group, LLC ($269K).

Company
Medicus Pharma Ltd.
CUSIP
58471K202
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q4 2024: 3Q4 2024Q1 2025: 7Q1 2025Q2 2025: 21Q2 2025Q3 2025: 20Q3 2025Q4 2025: 21Q4 2025Q1 2026: 21Q1 2026Q2 2026: 23Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions7$3.0M
Exits6$606K

All 13F filers, Q3 2025 → Q4 2025: 2,087,367 shares bought and 267,316 shares sold, net +1,820,051 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 21 holders

Armistice Capital, LLC 0.07% New 1,810,960 $2.8M
Interchange Capital Partners, LLC 0.45% No change 1,586,871 $2.4M
Private Advisor Group, LLC 0.00% Add +15.8% 175,495 $269K
Jane Street Group, LLC 0.00% New 60,337 $92K
Wilmington Savings Fund Society, FSB 0.00% Add +100.0% 51,244 $78K
Susquehanna International Group, LLP 0.00% New 40,162 $61K
May Hill Capital, LLC 0.01% Add +100.0% 35,622 $55K
BlackRock, Inc. 0.00% Add +111.6% 34,317 $53K
Commonwealth Equity Services, LLC 0.00% Add +161.8% 28,493 $44K
HRT Financial LP 0.00% New 27,529 $42K
Brave Asset Management Inc. 0.01% No change 20,000 $31K
Morgan Stanley 0.00% Add +206.7% 18,306 $28K
Smithfield Trust Co 0.00% New 13,883 $21K
UBS Group AG 0.00% Add +90.2% 13,231 $20K
Two Sigma Investments, LP 0.00% New 12,319 $19K
Osaic Holdings, Inc. 0.00% Reduce -39.3% 8,500 $13K
Larson Financial Group LLC 0.00% No change 1,000 $2K
Hazlett, Burt & Watson, Inc. 0.00% New 425 $1K
Jones Financial Companies LLLP 0.00% No change 400 $612
Dagco, Inc. 0.00% No change 349 $534
Wells Fargo & Company 0.00% No change 75 $115

"% of holder's portfolio" is MDCX's weight in each manager's 13F, not the share of Medicus Pharma Ltd. the manager owns.